Z., & Algarni, A
The phase two trial, which had 40 patients, was conducted in Croatia, and some people question the validity of the study due to its location, but the groups conducting the trials seem to be doing robust, randomized, control, double-blind, placebo-control trials 2m6s
The study suggests that GLP-1 therapy in this group led to increased costs without clear health benefits over the observed period
Nn s dng ng vi hng dn ca nhn vin t vn t hiu qu tt nht
Participants were categorized based on the duration of acne scars, as those with scars under 5 years, 610 years, and scars for more than 10 years and constituted 10 (50%), 7 (35%), and 3 (15%) in group A (dermaroller monotherapy), respectively, and 7 (35%), 11 (55%), 10 (15%) in group B (dermaroller with copper peptide), respectively